Clinical trial
Efficacy of Intravenous Levosimendan Compared With Dobutamine on Renal Hemodynamics and Function in Chronic Heart Failure
NCT02133105 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Intravenous Levosimendan Compared With Dobutamine on Renal Hemodynamics and Function in Chronic Heart Failure
- Lead sponsor
- Göteborg University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- May 31, 2017
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiorenal syndrome